Delivery Order SPE2DR25D2106-SPE2DR26F1FRE
- Not listed
- The Defense Logistics Agency awarded a $6,497.32 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector on October 21, 2025, with an ultimate completion date of November 12, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Benlysta 200 mg/ml auto-injectors. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, and represents a non-competitive set-aside award. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,082.67 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector pharmaceutical supplies. The contract was competitively awarded without set-aside designation and carries a completion date of October 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and military healthcare systems through its...
- The Defense Logistics Agency awarded a $18,496.02 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector pharmaceutical product on August 14, 2025, with completion targeted for September 5, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation, to be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injectors. The contract, which was competitively awarded without set-aside restrictions, carries a firm fixed price structure with an ultimate completion date of October 14, 2025. Performance will be executed from AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Benlysta 200 mg/mL auto-injector, valued at $6,165.34. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 12, 2025. The order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order on August 15, 2025, valued at $12,330.68 for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed price, non-set-aside delivery order with a completion deadline of September 8, 2025, and represents a child contract under AmerisourceBergen's larger federal contract vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on November 17, 2025. This is a firm fixed-price delivery order with a completion date of December 9, 2025, with no set-aside designation applied. The award represents a competitive procurement under AmerisourceBergen's existing contract vehicle with DLA, reflecting the company's established capability as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $6,165.36 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Benlysta 200 mg/mL auto-injector medication. This is a firm fixed-price contract with an ultimate completion date of November 21, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will occur at the...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Benlysta 200 mg/mL auto-injector units. The contract is classified as firm fixed price with an ultimate completion date of December 4, 2025, and carries no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the...
- SPE2DR25D2106Indefinite Delivery Contract
- SPE2DR25D2106-SPE2DR26F1FREDelivery Order
The Defense Logistics Agency awarded a $3,248.66 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Benlysta 200 mg/mL auto-injector. This is a firm fixed price, competitively awarded contract with an ultimate completion date of December 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order represents a single transaction under the company's broader federal contract portfolio with DLA. This delivery order operates as a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The contract supports multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key participant in the DLA's pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 11/17/25 |